HomeCompareBIOL vs JEPQ

BIOL vs JEPQ: Dividend Comparison 2026

BIOL yields 10000.00% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIOL wins by $55137509079256512.00M in total portfolio value
10 years
BIOL
BIOL
● Live price
10000.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55137509079256512.00M
Annual income
$54,073,795,673,722,890,000,000.00
Full BIOL calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — BIOL vs JEPQ

📍 BIOL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIOLJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIOL + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIOL pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIOL
Annual income on $10K today (after 15% tax)
$850,000.00/yr
After 10yr DRIP, annual income (after tax)
$45,962,726,322,664,450,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, BIOL beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIOL + JEPQ for your $10,000?

BIOL: 50%JEPQ: 50%
100% JEPQ50/50100% BIOL
Portfolio after 10yr
$27568754539628256.00M
Annual income
$27,036,897,836,861,443,000,000.00/yr
Blended yield
98.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BIOL right now

BIOL
Analyst Ratings
5
Buy
1
Hold
Consensus: Buy
Altman Z
-17.2
Piotroski
4/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIOL buys
0
JEPQ buys
0
No recent congressional trades found for BIOL or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIOLJEPQ
Forward yield10000.00%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$55137509079256512.00M$44.8K
Annual income after 10y$54,073,795,673,722,890,000,000.00$2,152.59
Total dividends collected$55066727460582336.00M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: BIOL vs JEPQ ($10,000, DRIP)

YearBIOL PortfolioBIOL Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$1,010,700$1,000,000.00$11,930$1,110.39+$998.8KBIOL
2$95,539,393$94,457,943.93$14,133$1,224.34+$95.53MBIOL
3$8,447,007,736$8,344,780,585.66$16,632$1,340.46+$8446.99MBIOL
4$698,565,746,383$689,527,448,105.17$19,454$1,457.97+$698565.73MBIOL
5$54,040,711,670,213$53,293,246,321,583.74$22,626$1,576.08+$54040711.65MBIOL
6$3,910,851,616,519,516$3,853,028,055,032,387.00$26,175$1,694.09+$3910851616.49MBIOL
7$264,781,167,546,477,440$260,596,556,316,801,570.00$30,133$1,811.32+$264781167546.45MBIOL
8$16,772,556,223,821,672,000$16,489,240,374,546,942,000.00$34,531$1,927.17+$16772556223821.64MBIOL
9$994,124,678,068,810,000,000$976,178,042,909,320,800,000.00$39,403$2,041.08+$994124678068810.00MBIOL
10$55,137,509,079,256,515,000,000$54,073,795,673,722,890,000,000.00$44,787$2,152.59+$55137509079256512.00MBIOL

BIOL vs JEPQ: Complete Analysis 2026

BIOLStock

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Full BIOL Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this BIOL vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIOL vs SCHDBIOL vs JEPIBIOL vs OBIOL vs KOBIOL vs MAINBIOL vs XYLDBIOL vs QYLDBIOL vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.